Physician profile
Trinava Roy
NPI 1417539966
$2,845.80
in general payments reported to CMS, 2019-2025
18 companies · $2,846 in 2025
The $2,846 reported for 2025 was more than what 98% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $2,846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $1,346 · Food and Beverage: $1,280 · Education: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $1,346.00 |
| Food and Beverage | $1,279.67 |
| Education | $220.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,682.84 | 2025 | Assurity, Thoratec Heartmate 3 Lvas Implant Kit, Tacticath |
| Atricure, INC. | $233.30 | 2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| E.R. Squibb & Sons, L.L.C. | $141.81 | 2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $139.25 | 2025 | Watchman Flx |
| Amgen INC. | $117.33 | 2025 | Repatha |
| Novartis Pharmaceuticals Corporation | $102.48 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $89.58 | 2025 | Lifevest |
| Abiomed | $83.31 | 2025 | |
| Kestra Medical Technology Services, INC. | $73.22 | 2025 | Assure Wcd |
| Novo Nordisk INC | $31.07 | 2025 | Wegovy |
| American Regent | $23.50 | 2025 | Injectafer |
| Edwards Lifesciences Corporation | $23.07 | 2025 | Sapien 3 Ultra Resilia |
| Heartflow, INC. | $22.83 | 2025 | |
| Merck Sharp & Dohme LLC | $18.97 | 2025 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $16.85 | 2025 | Opsumit, Uptravi |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $16.74 | 2025 | |
| Bridgebio Pharma, INC. | $16.08 | 2025 | Attruby |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.57 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trinava Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.